Conference Reports for NATAP

5th IAS Conference on HIV Pathogenesis, Treatment and Prevention July 19th-22nd 2009 Capetown, South Africa Back

Kaletra Once-Daily Dosing, IAS Summary       Comparable Safety and Efficacy With Once-daily (QD) Versus Twice-daily (BID) Dosing of Lopinavir/ritonavir (LPV/r) Tablets With Emtricitabine (FTC) + Tenofovir DF (TDF) in Antiretroviral (ARV)-naive, HIV-1-infected Subjects: 96-Week Results of the Randomized Trial M05-730 - (07/28/09)   Kaletra Once vs Twice Daily in treatment-experienced (07/22/09)   Once- and Twice-Daily Lopinavir/Ritonavir Equivalent in Antiretroviral Experienced - written by Mark Mascolini - (07/22/09)